AstraZeneca continues to advance its ambition to revolutionise cancer care with pivotal data presented for lung, gastrointestinal (GI), and breast cancers at the recent ESMO Asia Congress 2024. With a ...

The approval is the 14 th for Keytruda, extending its use into a tenth tumour type, and consolidates its position as the top-selling PD-1/PD-L1 drug ... Other companies with checkpoint inhibitors ...

SEOUL, Jan. 7 (Korea Bizwire) — As aging populations and chronic illnesses drive a shift in global healthcare toward ...

Winter Storm Cora brought more snow and ice than expected – two to four inches around the Metro – along with slick roads, ...

The global kids shampoo market is witnessing significant growth and innovation, with projections estimating the market size ...

A guiding service offers a pricey drug therapy (that's also illegal in professional sports) to get clients to the Everest ...

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The Himalaya, the highest mountain range in the world, stretches across Nepal, India, Bhutan, China, and Pakistan. The range is home to the fourteen 8,000-meter peaks - the highest mountains in ...

Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. By Brendan Borrell When Stephane Castel first ...

CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...